BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27041285)

  • 1. [Clinical Tests Testing New Therapies for Stargardt Disease].
    Kousal B; Ďuďáková Ľ; Hlavatá L; Lišková P
    Cesk Slov Oftalmol; 2016 Feb; 72(1):293-7. PubMed ID: 27041285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP-binding cassette subfamily A, member 4 intronic variants c.4773+3A>G and c.5461-10T>C cause Stargardt disease due to defective splicing.
    Jonsson F; Westin IM; Österman L; Sandgren O; Burstedt M; Holmberg M; Golovleva I
    Acta Ophthalmol; 2018 Nov; 96(7):737-743. PubMed ID: 29461686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations.
    Fujinami K; Lois N; Mukherjee R; McBain VA; Tsunoda K; Tsubota K; Stone EM; Fitzke FW; Bunce C; Moore AT; Webster AR; Michaelides M
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8181-90. PubMed ID: 24265018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapeutics for Stargardt disease.
    Lu LJ; Liu J; Adelman RA
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1057-1062. PubMed ID: 28285324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ULTRAWIDEFIELD AUTOFLUORESENCE IN ABCA4 STARGARDT DISEASE.
    Klufas MA; Tsui I; Sadda SR; Hosseini H; Schwartz SD
    Retina; 2018 Feb; 38(2):403-415. PubMed ID: 28248825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stargardt macular dystrophy and evolving therapies.
    Hussain RM; Ciulla TA; Berrocal AM; Gregori NZ; Flynn HW; Lam BL
    Expert Opin Biol Ther; 2018 Oct; 18(10):1049-1059. PubMed ID: 30129371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of Late-Onset Stargardt Disease.
    Lambertus S; Lindner M; Bax NM; Mauschitz MM; Nadal J; Schmid M; Schmitz-Valckenberg S; den Hollander AI; Weber BH; Holz FG; van der Wilt GJ; Fleckenstein M; Hoyng CB;
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5186-5191. PubMed ID: 27699414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New Treatments for Stargardt Disease and Related Retinal Degenerative Diseases].
    Arai E; Maeda A; Murakami A
    Nippon Ganka Gakkai Zasshi; 2017 Jan; 121(1):7-16. PubMed ID: 30079717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants in the
    Salles MV; Motta FL; Martin R; Filippelli-Silva R; Dias da Silva E; Varela P; Costa KA; Chiang JP; Pesquero JB; Sallum JF
    Mol Vis; 2018; 24():546-559. PubMed ID: 30093795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimenal studies On cell and gene therapies for retinal dystrophies with a particular focus On ABCA4 retinopathies.
    Sciezynska A; Ozieblo D; Oldak M
    Klin Oczna; 2016 Aug; 118(1):66-71. PubMed ID: 29715412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intronic ABCA4 c.5461-10T>C variant, frequently seen in patients with Stargardt disease, causes splice defects and reduced ABCA4 protein level.
    Aukrust I; Jansson RW; Bredrup C; Rusaas HE; Berland S; Jørgensen A; Haug MG; Rødahl E; Houge G; Knappskog PM
    Acta Ophthalmol; 2017 May; 95(3):240-246. PubMed ID: 27775217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stargardt-Fundus flavimaculatus: recent advancements and treatment.
    Haji Abdollahi S; Hirose T
    Semin Ophthalmol; 2013; 28(5-6):372-6. PubMed ID: 24138045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
    Sisk RA; Leng T
    Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-onset stargardt disease: phenotypic and genotypic characteristics.
    Lambertus S; van Huet RA; Bax NM; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
    Ophthalmology; 2015 Feb; 122(2):335-44. PubMed ID: 25444351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Therapy of ABCA4-Associated Diseases.
    Auricchio A; Trapani I; Allikmets R
    Cold Spring Harb Perspect Med; 2015 Jan; 5(5):a017301. PubMed ID: 25573774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options.
    Tanna P; Strauss RW; Fujinami K; Michaelides M
    Br J Ophthalmol; 2017 Jan; 101(1):25-30. PubMed ID: 27491360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Complex ABCA4 Alleles in Brazilian Patients With Stargardt Disease: Genotype-Phenotype Correlation.
    Salles MV; Motta FL; Dias da Silva E; Varela P; Costa KA; Filippelli-Silva R; Martin RP; Chiang JP; Pesquero JB; Sallum JMF
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5723-5730. PubMed ID: 29114839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease.
    Chen Y; Ratnam K; Sundquist SM; Lujan B; Ayyagari R; Gudiseva VH; Roorda A; Duncan JL
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3281-92. PubMed ID: 21296825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Molecular Properties of ABCA4 and Its Role in the Visual Cycle and Stargardt Disease.
    Molday RS
    Prog Mol Biol Transl Sci; 2015; 134():415-31. PubMed ID: 26310168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel pathogenic
    Xiang Q; Cao Y; Xu H; Guo Y; Yang Z; Xu L; Yuan L; Deng H
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30563929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.